Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Not sure what is going on. Nothing has changed fundamentally but the SP has been decimated. This one caught me off guard as it has such great fundamental characterisitcs. Such a shame. I had loaded heavily in the $11.20's to average down and this was clearly a poor decision.
Been meaning to do it for the last few day. I will get on it soon.
They are sitting on almost $70M in cash. That's pretty good and they make $10M a year from their products. They also have a $15M credit line available to them.
Agree. Look forward to the coming weeks.
Nice entry. I need to get better at that part of my trading. Well played. I think she has great potential but will require a little patience.
Thanks for listening Bob! This one will be dynamite.
Slow and steady.
Been watching for a while. Could be s good reversal a story if/when it bottoms.
Should make a solid move into May with data.
Thanks Bob! Some sellers here but with a little patience, I think this will be rewarding.
VYGR Due Diligence
This one started a nice run on Friday but I think it has some legs left. Defined catalyst date on 4/27 should bring in a lot more investors.
http://jbemtrading.com/category/VYGR
CORI Due Diligence
This is a solid play. Not much glitz and glam, but a truly great set up. Chart is primed. Proven technology, proven drug, combine the two and address a $5.5B market. Easy peezy.
http://jbemtrading.com/category/CORI
APVO Due Diligence
When completing the DD on this one, the story was almost too good to be true. Research this one for yourselves. Fantastic story.
http://jbemtrading.com/category/APVO
I’m Putting the Band Back Together
It is with great pleasure that I compose this message. I took the last year off from investing due to various reason, but I am ready to again share high quality due diligence on emerging growth life science companies. Over the last month I reviewed 1000+ life science companies, read hundreds of SEC forms, viewed countless investor presentations, and listened to more conference calls that I ever wanted. From that I put together one of the most stellar watch lists that I can remember. I look forward to sharing these companies in the coming weeks and months, but before I get ahead of myself let me share my story.
2016…A Year to Forget
As many here know, 2015 was an epic year. After achieving over 200% in gains for the year I was excited for 2016. Unfortunately, shortly after the new year my youngest son became sick and doctors were initially unable to diagnose his condition. Following three trips to the emergency room in three days he was admitted and eventually diagnosed with a rare disease. After several weeks in the hospital and countless tests, the cause of his illness was determined to be a bacterial infection from Nocardia or Nocardosis. This is a very rare disease infecting only 500-1000 individuals worldwide per year and typically immunocompromised patients. After many consults with various providers throughout the country an effective treatment was found. After three weeks in the hospital he could come home. At home, he needed IV antibiotics and then six more months of oral antibiotics. Now he is in perfect health with no immune deficiencies and is a rambunctious, hilarious 3.5 year old boy.
During his illness and recovery, I was approached by individuals working as advisors in the small/microcap space. They had noted my previous years returns, ability to research high quality companies, and then share these companies in a way that was well received by regular investors. Many ideas were discussed and it was determined that we were going to start an investor relations firm utilizing digital media. IR firm methodology is outdated and they do not utilize technology that most investors use today. Considerable effort was extended to set up the digital infrastructure while complying with regulatory agencies such as FINRA. In August 2016, we rolled out the new enterprise and were well received by many companies. As the enterprise engaged with more companies; interpersonal issues within the group developed and ultimately lead to the demise of the enterprise in November.
At that point I was mentally and physically exhausted. The series of events beginning with my son’s illness followed by the stress of establishing a new business with partners had taken its toll on my family and myself. I withdrew from investing and isolated myself for the next three months reflecting on what the course was for myself and my family. Through careful introspection I determined my future plans.
2017… The Path Forward
Looking back at the events of the last three years, I realize that I was the happiest during the initial days of JBEM. I enjoyed researching life science companies, completing due diligence, and sharing the information with other investors. The market is a tough place, especially the life science sector, and sharing the information I put together with other investors was rewarding. Using the knowledge and lessons I learned over the last year, I have decided to bring JBEM back. My experience working with the advisors in small cap reaffirmed many of my beliefs about the money that drives this sector and added insights that now influence my due diligence. Additionally, investor demographics are rapidly evolving and it is important to share products that can accurately and succinctly present an investment thesis. I intend to utilize new methods of sharing my due diligence; particularly through various digital formats. I look forward to sharing my due diligence with all of you in the future and hope that you find the information that I share and the products that I develop beneficial to you as an investor.
To receive my due diligence and trading updates in the future, please sign up to my new email list at jbemtrading.com.
Thank you, and I wish you all the best in your endeavors.
Josh (JBEM)
That's great. LOL!
$BIOAF Next biotech runner. bit.ly/2evfkUE
$BIOAF Next biotech runner. bit.ly/2evfkUE
I would like to see $2.10 and above before I start peeling off shares.
This is set to rip in the next couple days.
In this market, data good or bad is a liability. Take this profits and know your account grew. I made my trading strategy clear to everyone who has decided to join the Rising Tide Equity Forum.
You guys crack me up. There is no more JBEM "and his boys." I knocked out all the pumpers, took down the Google group and have absolutely no following. Case in point, ARQL. Profits were taken in the $1.40's when big blocks started showing up on the ask and R3 at $1.50ish acted as strong resistance. Euphoria was running high on the boards and is another strong indication it's time to trim a position. I'll hold a few shares as a book mark, but without any major news, an RS is imminent. RS, offering, then we hope for something big.
Exactly, you need to have a strategy when entering a stock. Buying without determining what you intend to do sets up the situation in which emotion guides investing decisions. Set goals, execute, profit.
Some of you guys act as if taking profits is a bad thing. I rode this from $.87 to 1.20-1.30 the first time. Reloaded at $1 and took SOME off the table above $1.40 while holding a core. If she runs hard next week, I still own shares, if she dips, I get to add even more. This is going much higher, but taking profits and growing a position is smart regardless of your philosophy. Data releases in this market are a pure gamble even with positive data. How many companies have you seen in the last 6 months get decimated on positive data. Everyone knows the data is good, this is now about exposure. That takes time.
IHUB wont let me post links but if you Google Rising Tide Equity, I am the 7th one down. Go to the forum option and sign up.
I am publishing a new equity report in the next 30 minutes. You will have to be signed up to see it.
FYI- CYDY Equity report and press release are getting pounded. My approach works.
I am doing a 30 day trail membership right now so anyone that wants to see what I have going on, my watch list, etc, it's open for everybody. I will be releasing another DD there tomorrow or the next day and will then PR it next week.
Slow and steady, churning up, with new buyers coming in. I don't anticipate a spike, but controlled movement as more people are made aware. Over 1500 people have read the press release and more views are coming in.
Thanks, the world needs to know.
How many people here retweeted or shared the press release from this morning, directing people to the equity report? - I saw wallstreetTA did.
It's coming out slowly. I am in contact with them to find out about the delay. It was scheduled for 0630. At least it is going out now.
This sould have also hit some other major news outlets. I have pinged accesswire as why it hasn't been published yet.
Share it. We now have the content to let it spread.
50k shares.
Trust me when I tell you CYDY is going to get a lot more attention on Monday. Lets just make sure the information is shared in as many places as possible. ;)
LOL! That guy shouldn't be allowed to invest.
He didn't seem too concerned about it. They will get one way or another. Torture a few mice and get it or start the trial and submit the patient data and get it. I think they will likely go the patient data route as it does not cost anymore $$$ that what is already figured into the trial.
I still want to know which one of you is Ron Sanchez. HAHA!
Which ones? They will submit the ODD again, they will likely just use data from their patients or run a quick animal study.
LOL! I just needed to take notes. Doing a little more writing. I hope none of you guys are Ron Sanchez. Seriously, did that guy listen to the CC and who in the world thinks that they will disclose patient information.
I added 10K earlier this week below $1 so make that 50k. LOL!
May conference call- I am in desperate need of the link to the call or the transcript. Does anybody know where I can get it. It appears to have been taken down from their website.